Okay @danielyu & @Arno what about the secondary part of this with the Atlas Of Economic Complexity resources?
Wouldn’t it be helpful to use some of these tools/​data to come up with the highest potential impact ventures to support?
Like maybe one could look for what African countries have the highest similarity scores /​ adjacent capabilities to start building more generics pharmaceutical industries to support the region’s global health goals.
Or what countries may be most able to develop very low-cost meat alternatives /​ plant-based protein products for better animal welfare?
Like are there opportunities for donors to support both private business in low income countries & other high impact cause areas simultaneously?
100% there are, and there are a lot of companies trying to do very aligned things. (Generic pharmaceuticals are actually hilariously cheap in Africa already thanks to India though.)
There already are very low cost meat alternative plant proteins that exist in east africa at least.
Many of the issues lie in boring things like operations, marketing, distro and financing.
Okay @danielyu & @Arno what about the secondary part of this with the Atlas Of Economic Complexity resources?
Wouldn’t it be helpful to use some of these tools/​data to come up with the highest potential impact ventures to support?
Like maybe one could look for what African countries have the highest similarity scores /​ adjacent capabilities to start building more generics pharmaceutical industries to support the region’s global health goals.
Or what countries may be most able to develop very low-cost meat alternatives /​ plant-based protein products for better animal welfare?
Like are there opportunities for donors to support both private business in low income countries & other high impact cause areas simultaneously?
100% there are, and there are a lot of companies trying to do very aligned things. (Generic pharmaceuticals are actually hilariously cheap in Africa already thanks to India though.)
There already are very low cost meat alternative plant proteins that exist in east africa at least.
Many of the issues lie in boring things like operations, marketing, distro and financing.